335 related articles for article (PubMed ID: 17867555)
1. Solid dispersion of spironolactone with porous silica prepared by the solvent method.
Uchino T; Yasuno N; Yanagihara Y; Suzuki H
Pharmazie; 2007 Aug; 62(8):599-603. PubMed ID: 17867555
[TBL] [Abstract][Full Text] [Related]
2. Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method.
Takeuchi H; Nagira S; Yamamoto H; Kawashima Y
Int J Pharm; 2005 Apr; 293(1-2):155-64. PubMed ID: 15778053
[TBL] [Abstract][Full Text] [Related]
3. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
4. Stability of amorphous drug, 2-benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2H-pyridazin-3-one, in silica mesopores and measurement of its molecular mobility by solid-state (13)C NMR spectroscopy.
Miura H; Kanebako M; Shirai H; Nakao H; Inagi T; Terada K
Int J Pharm; 2011 May; 410(1-2):61-7. PubMed ID: 21421036
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the microstructure of semicrystalline solid dispersions.
Zhu Q; Taylor LS; Harris MT
Mol Pharm; 2010 Aug; 7(4):1291-300. PubMed ID: 20550195
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Maghsoodi M; Sadeghpoor F
Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol dissolution improvement by preparation of solid dispersions with porous silica.
Planinšek O; Kovačič B; Vrečer F
Int J Pharm; 2011 Mar; 406(1-2):41-8. PubMed ID: 21219991
[TBL] [Abstract][Full Text] [Related]
8. Preparation of a solid dispersion of felodipine using a solvent wetting method.
Kim EJ; Chun MK; Jang JS; Lee IH; Lee KR; Choi HK
Eur J Pharm Biopharm; 2006 Oct; 64(2):200-5. PubMed ID: 16750355
[TBL] [Abstract][Full Text] [Related]
9. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
[TBL] [Abstract][Full Text] [Related]
10. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG), talc, and PEG-talc as dispersion carriers.
Khan GM; Jiabi Z
Drug Dev Ind Pharm; 1998 May; 24(5):455-62. PubMed ID: 9876608
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical Properties of Ursodeoxycholic Acid Dispersed in Controlled Pore Glass.
Okonogi S; Oguchi T; Yonemochi E; Puttipipatkhachorn S; Yamamoto K
J Colloid Interface Sci; 1999 Aug; 216(2):276-284. PubMed ID: 10421735
[TBL] [Abstract][Full Text] [Related]
13. Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.
DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
Eur J Pharm Sci; 2010 Jun; 40(3):179-87. PubMed ID: 20230894
[TBL] [Abstract][Full Text] [Related]
14. Alternative solvent-free preparation methods for felodipine surface solid dispersions.
Kerc J; Srcic S; Kofler B
Drug Dev Ind Pharm; 1998 Apr; 24(4):359-63. PubMed ID: 9876596
[TBL] [Abstract][Full Text] [Related]
15. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of azithromycin--Aerosil 200 solid dispersions with enhanced physical stability.
Li X; Peng H; Tian B; Gou J; Yao Q; Tao X; He H; Zhang Y; Tang X; Cai C
Int J Pharm; 2015; 486(1-2):175-84. PubMed ID: 25794608
[TBL] [Abstract][Full Text] [Related]
17. Dissolution behaviour of nalidixic acid solid dispersions using water soluble dispersion carriers.
Mallick S; Sahu A; Pal K
Acta Pol Pharm; 2004; 61(1):21-30. PubMed ID: 15259854
[TBL] [Abstract][Full Text] [Related]
18. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
[TBL] [Abstract][Full Text] [Related]
19. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
20. Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing.
Overhoff KA; Moreno A; Miller DA; Johnston KP; Williams RO
Int J Pharm; 2007 May; 336(1):122-32. PubMed ID: 17184938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
